The ability of normal tissues to mount an angiogenic response in a precise and regulated manner is fundamental to normal physiological processes such as wound healing. The process of angiogenesis is initiated by vascular endothelial cells and involves the orderly migration, proliferation and differentiation into new capillary channels. Cultured human umbilical vein endothelial cells (HUVEC) express many of the characteristics of the endothelium in vivo and are used as a model system to investigate the mechanisms of angiogenesis. For example, HUVEC proliferate in response to fibroblast growth factor (FGF)-l and are growth arrested by cytokines. The tumor promoter phorbol myristic acetate (PMA) serves as an example of a biochemical agent able to repress FGF-1-induced HUVEC growth in vitro. Prolonged treatment of HUVEC with PMA results in the formation of differentiated capillary-like tubular structures. To study the transcriptional events in angiogenesis, we have cloned several immediate-early (IE) genes induced by PMA in HUVEC. Analogous to growth factor-inducible IE genes, PMA-inducible IE genes may mediate key, regulatory events in endothelial cell growth inhibition and/or differentiation. A novel PMA-inducible IE gene, termed edg-1 was cloned and characterized. It encodes a novel G-protein-coupled receptor (GPR) polypeptide. The ligand for the edg-1 receptor as well as the signal transduction pathways regulated by edg-1 are unknown at present. Because the edg-1 mRNA is an IE gene induced by angiogenic stimuli, and because high-levels of edg-1 transcript are expressed in endothelial cells, it may be involved in the regulation of signal transduction events intrinsic to angiogenesis. This proposal will attempt to define the edg-l-regulated signal transduction mechanisms by using the chimeric receptor approach. The ability of edg-1 to modulate the in vitro angiogenic phenomenon of endothelial cells will be assessed as well. Furthermore, we will test whether known vasoactive and angiogenic response modifiers are ligands for edg-1. These experiments will systematically examine the ability of candidate ligands to activate the transfected edg-1 receptors. In addition, this proposal will attempt to characterize the in vitro expression and in vivo correlates of edg-1 polypeptide expression in angiogenesis that occurs during wound healing. The expression patterns of G-protein isotypes during migration, proliferation and differentiation of endothelial cells will be studied. Since dysregulated angiogenesis is a hallmark of many diseases including diabetic retinopathy, glomerulonephritis, impaired wound healing and solid tumor growth, the proposed characterization of edg-1 as a regulator of angiogenesis in vitro may be of value in the understanding the pathogenesis of many human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK045659-01
Application #
3247165
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1992-09-30
Project End
1996-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Thompson, Brian; Ancellin, Nicolas; Fernandez, Salvador M et al. (2006) Protein kinase Calpha and sphingosine 1-phosphate-dependent signaling in endothelial cell. Prostaglandins Other Lipid Mediat 80:15-27
Goligorsky, Michael S; Brodsky, Sergey V; Noiri, Eisei (2004) NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Semin Nephrol 24:316-23
Ozaki, Harunobu; Hla, Timothy; Lee, Menq-Jer (2003) Sphingosine-1-phosphate signaling in endothelial activation. J Atheroscler Thromb 10:125-31
Ancellin, Nicolas; Colmont, Chantal; Su, Joseph et al. (2002) Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 277:6667-75
Lee, M J; Thangada, S; Paik, J H et al. (2001) Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 8:693-704
Paik, J H; Chae Ss; Lee, M J et al. (2001) Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 276:11830-7
Hla, T (2001) Sphingosine 1-phosphate receptors. Prostaglandins Other Lipid Mediat 64:135-42
Kluk, M J; Hla, T (2001) Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res 89:496-502
Hla, T; Lee, M J; Ancellin, N et al. (2001) Lysophospholipids--receptor revelations. Science 294:1875-8
Morales-Ruiz, M; Lee, M J; Zollner, S et al. (2001) Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276:19672-7

Showing the most recent 10 out of 28 publications